COVID-19 Tanısı ile Takipliyken Akut Mukormikoz Gelişen İki Olgu
- 30 September 2021
- journal article
- research article
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (3), 550-555
- https://doi.org/10.5578/flora.20219724
Abstract
Coronavirus disease 2019 (COVID-19) has caused an on-going pandemic since March 2020. It has been shown with clinical studies that patients with chronic illnesses, notably diabetes mellitus, are under high risk of complications including death. Mucormycosis is invasive and fulminant even though it is rare. Although there are numerous studies existing in the literature about COVID-19 cases with invasive Aspergillosis, there are a couple of studies reported about COVID-19 cases with mucormycosis. In this study, it was aimed to present two cases of COVID-19 with diabetes and acute rhino-orbital-cerebral mucormycosis. Early diagnosis and treatment of mucormycosis is crucial to decrease morbidity and mortality.Keywords
This publication has 14 references indexed in Scilit:
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19Journal of Infection, 2020
- Invasive fungal diseases during COVID-19: We should be preparedJournal de Mycologie Medicale, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injuryThe Lancet, 2020
- Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolatesPLOS ONE, 2017
- Rhino-orbital Mucormycosis Treated Successfully with Posaconazole without ExenterationNeuro-Ophthalmology, 2013
- Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007Clinical Microbiology & Infection, 2011
- Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have ZygomycosisClinical Infectious Diseases, 2008
- Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and ManagementClinical Microbiology Reviews, 2005